Uncategorized
VIDEO: Surgeon presents phase 3 clinical trial results of Rhopressa
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, L. Jay Katz, MD, FACS, discusses phase 3 clinical trial results of Aerie Pharmaceuticals' netarsudil ophthalmic solution 0.02%, also called Rhopressa, for lowering IOP in glaucoma patients.